Evidence map›Paper›PMID 30511478›Full record

ArticleGenetic epidemiology2019

Loss of function, missense, and intronic variants in NOTCH1 confer different risks for left ventricular outflow tract obstructive heart defects in two European cohorts.

Emmi Helle, Aldo Córdova-Palomera, Tiina Ojala, Priyanka Saha, Praneetha Potiny, Stefan Gustafsson, Erik Ingelsson, Michael Bamshad, Deborah Nickerson, Jessica X Chong and 3 more

Abstract read
In one paragraph

Article in Genetic epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Human Genetics of Semilunar Valve and Aortic Arch Anomalies.Advances in experimental medicine and biology · 2024
    Review
  8. Article
  9. Considering the Genetic Architecture of Hypoplastic Left Heart Syndrome.Journal of cardiovascular development and disease · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Emmi HellePediatric Research Center, Children's Hospital, University of Helsinki, Helsinki, Finland.
Aldo Córdova-PalomeraDepartment of Pediatrics, Division of Pediatric Cardiology, Stanford University School of Medicine, Stanford, CA.
Tiina OjalaPediatric Research Center, Children's Hospital, University of Helsinki, Helsinki, Finland.
Priyanka SahaDepartment of Pediatrics, Division of Pediatric Cardiology, Stanford University School of Medicine, Stanford, CA.
Praneetha PotinyDepartment of Pediatrics, Division of Pediatric Cardiology, Stanford University School of Medicine, Stanford, CA.
Stefan GustafssonDepartment of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Erik IngelssonDivision of Cardiovascular Medicine, Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA.
Michael BamshadDepartment of Pediatrics, University of Washington, Seattle, WA.
Deborah NickersonDepartment of Genome Sciences, University of Washington, Seattle, WA.
Jessica X ChongDepartment of Pediatrics, University of Washington, Seattle, WA.
University of Washington Center for Mendelian Genomics
Euan AshleyDivision of Cardiovascular Medicine, Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA.
James R PriestDivision of Cardiovascular Medicine, Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA.ORCID 0000-0002-8349-4784
Stanford Medicine · USUniversity of Helsinki · FIUniversity of Washington · USUppsala University · SESeattle Children's Hospital · USStanford University · US

Funding

UW Center for Mendelian GenomicsU54HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, NICKERSON, DEBORAH A · 2012 to 2015
$20.0M
UW Center for Mendelian GenomicsUM1HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, LEAL, SUZANNE M · 2016 to 2020
$15.3M
Genetic Mechanisms of Congenital Heart DiseaseR00HL130523 · NHLBI · STANFORD UNIVERSITY · PI PRIEST, JAMES R. · 2017 to 2019
$747k
Genetic Mechanisms of Congenital Heart DiseaseK99HL130523 · NHLBI · STANFORD UNIVERSITY · PI PRIEST, JAMES R. · 2016 to 2017
$306k
Medical Research Council MC_PC_17228Medical Research Council MC_QA137853NHGRI NIH HHS U54 HG006493NHGRI NIH HHS UM1 HG006493NHLBI NIH HHS K99 HL130523NHLBI NIH HHS R00 HL130523NIH HHS HG006493NIH HHS K99HL130523
6 · The paper itself

Abstract

Loss of function variants in NOTCH1 cause left ventricular outflow tract obstructive defects (LVOTO). However, the risk conferred by rare and noncoding variants in NOTCH1 for LVOTO remains largely uncharacterized. In a cohort of 49 families affected by hypoplastic left heart syndrome, a severe form of LVOTO, we discovered predicted loss of function NOTCH1 variants in 6% of individuals. Rare or low-frequency missense variants were found in 16% of families. To make a quantitative estimate of the genetic risk posed by variants in NOTCH1 for LVOTO, we studied associations of 400 coding and noncoding variants in NOTCH1 in 1,085 cases and 332,788 controls from the UK Biobank. Two rare intronic variants in strong linkage disequilibrium displayed significant association with risk for LVOTO amongst European-ancestry individuals. This result was replicated in an independent analysis of 210 cases and 68,762 controls of non-European and mixed ancestry. In conclusion, carrying rare predicted loss of function variants in NOTCH1 confer significant risk for LVOTO. In addition, the two intronic variants seem to be associated with an increased risk for these defects. Our approach demonstrates the utility of population-based data sets in quantifying the specific risk of individual variants for disease-related phenotypes.

Indexed as

Genetic Predisposition to DiseaseCohort StudiesExome SequencingFemaleHeart Defects, CongenitalHumansIntronsLoss of Function MutationMaleMutation, MissensePedigreeReceptor, Notch1Risk FactorsVentricular Outflow ObstructionWhite PeopleNOTCH1 protein, humanReceptor, Notch1congenital heart defectsleft ventricular outflow tract obstruction (LVOTO)NOTCH1UK Biobank

Identifiers

PMID30511478
PMCPMC6375786
OpenAlexW2950752134

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.